Docs often fall short when prescribing new drugs
685810
NEW YORK  - Physicians frequently fail to   provide patients with all the information they should have when   they're prescribed new medication, investigators in California   report.
337232
Two potentially new classes of anti-HIV drugs have the medical world excited. But progress on a vaccine is still slow  -  and drugs can't do everything
425170
Faced with weak development pipelines that are putting a drag on stock prices, drug manufacturers are retooling the decades-old system of clinical trials to make it faster and cheaper.
330991
Doctors are missing key information they need to make decisions for cancer patients because some drug companies are not publishing clinical trials.
436907
More openness is needed over clinical drug trial results  to stop them being distorted, leading medical journals say.
125115
If they want more new drugs, they shouldn't be looking at the pharmaceutical industry.
600288
Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take.
308786
Many doctors refuse to admit that simple chance is a factor in how well some of their patients do.
48148
Be aware of the Medicare drug plan's gaps.
344028
Patients in trials of drug treatments are being left in the lurch when the research finishes, doctors say.
505725
A decade after the government began trying to ensure that prescription drugs used to treat children work and are safe, doctors still have scant information to guide them when they administer many medications to kids.
535971
A growing number of children are taking combinations of powerful medications, but there is little evidence to justify the multiplication.
76414
From prescribing overdoses to sticking a tube in the wrong vein, doctors-in-training made one-third more serious mistakes during typically long shifts than they did during &quot;short&quot; 16-hour ones, a Harvard study found.
376526
Many doctors prescribe medicine without providing detailed information about it to patients, a new study suggests.
236669
With yet more already-marketed medicines raising the ire of consumer advocates and regulators alike, momentum is building for reform of the governmentâs drug approval and monitoring procedures.
614229
Even if regulators do not force Pfizer to withdraw Celebrex, its prospects are dim if doctors stop prescribing it in the volume they have in recent years.
2991
After a shaky start, Massachusetts doctors are beginning to embrace a new way of getting medications to their patients: e-prescribing.